Mereo BioPharma Group plc (MREO)

Mereo BioPharma Group Statistics

Total Valuation

MREO has a market cap or net worth of $615.96 million. The enterprise value is $534.69 million.

Market Cap	615.96M
Enterprise Value	534.69M

Important Dates

The next estimated earnings date is Monday, November 18, 2024, before market open.

Earnings Date	Nov 18, 2024
Ex-Dividend Date	n/a

Share Statistics

MREO has 153.61 million shares outstanding. The number of shares has increased by 12.05% in one year.

Current Share Class	n/a
Shares Outstanding	153.61M
Shares Change (YoY)	+12.05%
Shares Change (QoQ)	+1.64%
Owned by Insiders (%)	3.30%
Owned by Institutions (%)	36.78%
Float	97.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	7.83
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	534.69
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.07, with a Debt / Equity ratio of 0.08.

Current Ratio	6.07
Quick Ratio	5.78
Debt / Equity	0.08
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-22.39

Financial Efficiency

Return on equity (ROE) is -48.47% and return on invested capital (ROIC) is -27.87%.

Return on Equity (ROE)	-48.47%
Return on Assets (ROA)	-23.86%
Return on Capital (ROIC)	-27.87%
Revenue Per Employee	$30,303
Profits Per Employee	-$1.12M
Employee Count	33
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	-532,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +91.87% in the last 52 weeks. The beta is 0.97, so MREO's price volatility has been similar to the market average.

Beta (5Y)	0.97
52-Week Price Change	+91.87%
50-Day Moving Average	4.35
200-Day Moving Average	3.74
Relative Strength Index (RSI)	38.94
Average Volume (20 Days)	548,941

Short Selling Information

Short Interest	5.16M
Short Previous Month	4.88M
Short % of Shares Out	3.98%
Short % of Float	n/a
Short Ratio (days to cover)	6.58

Income Statement

In the last 12 months, MREO had revenue of $1.00 million and -$36.85 million in losses. Loss per share was -$0.26.

Revenue	1.00M
Gross Profit	1.51M
Operating Income	-37.90M
Pretax Income	n/a
Net Income	-36.85M
EBITDA	-37.31M
EBIT	-37.90M
Loss Per Share	-$0.26

Balance Sheet

The company has $87.43 million in cash and $6.16 million in debt, giving a net cash position of $81.27 million or $0.53 per share.

Cash & Cash Equivalents	87.43M
Total Debt	6.16M
Net Cash	81.27M
Net Cash Per Share	$0.53
Equity (Book Value)	78.65M
Book Value Per Share	0.51
Working Capital	78.47M

Cash Flow

Operating Cash Flow	-20.03M
Capital Expenditures	n/a
Free Cash Flow	-20.03M
FCF Per Share	-$0.13

Margins

Gross Margin	150.90%
Operating Margin	-3,790.40%
Pretax Margin	-3,737.90%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MREO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.05%
Shareholder Yield	-12.05%
Earnings Yield	-5.98%
FCF Yield	-3.25%

Analyst Forecast

The average price target for MREO is $7.50, which is 87.03% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.50
Price Target Difference	87.03%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	60.72%
EPS Growth Forecast (5Y)	-31.98%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MREO has an Altman Z-Score of 4.9 and a Piotroski F-Score of 3.

Altman Z-Score	4.9
Piotroski F-Score	3